baber/WOPTO huggingface dataset:
Patent CA-2883698-A1 (CA)
Title: Dispositif d'assistance respiratoire, appareil nasal et masque d'assistance respiratoire
Inventor: BOUSSIGNAC GEORGES
IPC: A61M16/12
Filed: 2013-08-28
Abstract: Dispositif d'assistance respiratoire (1) pour un patient comportant un élément tubulaire formant un canal principal (5) qui est destiné à être relié par son extrémité distale (7) à une voie respiratoire du patient, ledit canal principal reliant à l'extérieur le système respiratoire dudit patient par son extrémité proximale (6), ledit dispositif comportant en outre au moins un canal auxiliaire (8) permettant l'injection de jets de gaz respirable(s) destiné(s) à la ventilation dudit patient par des orifices de sortie distaux (17) du/des canaux auxiliaires, lesdits orifices de sortie débouchant dans ledit canal principal au voisinage de l'extrémité distale de ce dernier. Le dispositif comporte au moins un orifice de sortie en forme de bande annulaire ou semi-annulaire résultant de la réunion d'au moins certains des orifices de sortie distaux (17), l'épaisseur de l'orifice de sortie en forme de bande étant inférieure à 150 microns.
Patent CA-2883874-A1 (CA)
Title: Nasal stimulation devices and methods
Inventor: ACKERMANN DOUGLAS MICHAEL
IPC: A61N1/30
Filed: 2014-04-18
Abstract: Described here are devices, systems, and methods for treating one or more conditions (such as dry eye) or improving ocular health by providing stimulation to nasal or sinus tissue. Generally, the devices may be handheld or implantable. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs. When the devices and systems are used to treat dry eye, nasal or sinus tissue may be stimulated to increase tear production, reduce the symptoms of dry eye, and/or improve ocular surface health.
Patent CA-2884750-A1 (CA)
Title: A pharmaceutical composition
Inventor: SPLEISS JOHANNES
IPC: A61K9/48
Filed: 2013-09-06
Abstract: Shelf life of soft gelatin capsules comprising a soft gelatin shell encapsulating a pharmaceutical formulation comprising cis-5,8,11,14,17-eicosapentaenoic acid (C20:5 n-3; "EPA") in free acid form in an amount from 25 wt % to 99 wt % of the formulation and cis-7,10,13,16,19-docosapentaenoic acid (C22:5 n-3; "DPA") in free acid form in an amount from 1 wt % to75 wt % of the formulation in which the gelatin component of the shell is Type B gelatin, is improved by replacing up to 75 wt % of the gelatin component with porcine Type A gelatin.
Patent CA-2885078-A1 (CA)
Inventor: LYNCH MICHAEL A
IPC: G01P15/18
Filed: 2015-03-16
Abstract: A system for evaluating a physical location of a node in a network comprising a multi-axis accelerometer installed in proximity to the node and in a deterministic spacial orientation, and/or a controller configured to receive an acceleration vector associated with the multi-axis accelerometer and to evaluate the orientation of the node based on the received acceleration vector in comparison to a reference acceleration vector known to the controller and a look-up table in memory configured to contain the logical function and a node location identifier for each spatial orientation. The node may comprise a system component.
Patent CA-2887343-A1 (CA)
Inventor: CARLI MAURIZIO
IPC: B63H5/16
Filed: 2013-10-10
Abstract: A boat comprising a hull (10) and a propulsion means (3) suitably coupled to an inboard drive means (8), characterized in that said hull (10) is provided with at least one hollow (2) suitably shaped to at least partially accommodate said propulsion means (3), said hollow (2) being provided with at least one tube (21) and at least one atmospheric-pressure air intake (220) in such a way that the propulsion means, that is a surface propeller (3), can continuously operate under optimal conditions with respect to the thus-generated artificial water surface.
Patent CA-2889886-A1 (CA)
Inventor: ZHENG NING
IPC: H04N1/60
Filed: 2013-10-30
Abstract: A system and method for correcting colors in an image in order to identify pills. The system includes a surface that includes a background upon which pills are positioned and a border of known color adjacent to the background. The system also includes a digital camera and a processor. The processor is used to receive and process the image, use target objects on the surface to identify areas of the image that correspond to the known characteristics and features of the surface, perform image diagnostics to determine if the image can be used, and correct image color based on comparison of identified areas of the image that correspond with the known characteristics and features of the surface. Various graphical displays or cues can assist a user in obtaining a usable image.
Patent CA-2890385-A1 (CA)
Title: Methodes de traitement de maladies associees a s. aureus
Inventor: SELLMAN BRET
IPC: A61K39/085
Filed: 2013-11-05
Abstract: La présente invention se rapporte à des méthodes de prévention et/ou de traitement de bactériémie et de septicémie associées à S. aureus, et à des méthodes de prévention et/ou de traitement de pneumonie associée à S. aureus chez des patients immunovulnérables à l'aide d'anticorps anti-alpha toxine (anti-AT) de S. aureus. L'invention se rapporte également à des méthodes de réduction de charge bactérienne de S. aureus dans la circulation sanguine ou dans le cur d'un sujet mammifère, lesdites méthodes consistant à administrer au sujet une quantité efficace d'un anticorps anti-alpha toxine (anti-AT) de S. aureus isolé ou d'un fragment de liaison à l'antigène associé. L'invention se rapporte en outre à des méthodes de réduction d'agglutination bactérienne de S. aureus et/ou de formation de lésion thromboembolique chez un sujet mammifère, lesdites méthodes consistant à administrer au sujet une quantité efficace d'un anticorps anti-alpha toxine (anti-AT) de S. aureus isolé ou d'un fragment de liaison à l'antigène associé. L'invention se rapporte encore en outre à des méthodes de prévention ou de réduction de la gravité d'une pneumonie associée à S. aureus chez un sujet mammifère immunovulnérable.
Patent CA-2891597-A1 (CA)
Inventor: BOHRA HEMANT
IPC: B22C9/02
Filed: 2013-12-12
Abstract: A method of creating a sand mold for rapid casting, including the steps of determining a mold shape, providing a generally uniform thickness layer of sand, curing at least a portion of the layer of sand, machining the cured portions of the layer of sand based on the desired mold shape, and repeating the layer-forming, curing and machining steps until the sand mold is complete. Another aspect includes a machine for creating the sand mold having a build envelope defined by side walls, a movable build platform and at least one movable tool assembly, the movable tool assembly having a single or plurality of tools chosen from the group consisting of a sand dispenser, a sand leveling device, a curing device, and a machining device.
Patent CA-2897267-A1 (CA)
Title: Steel plate and concrete composite tank unit, tank group and offshore platforms
Inventor: WU ZHIRONG
IPC: B65D88/78
Filed: 2013-01-22
Abstract: A unitary barrel of a steel plate and concrete composite structure, a unitary group barrel, and an offshore platform. The unitary barrel comprises: a concrete outer barrel comprising an outer barrel body and, arranged at two ends of the outer barrel body, a sealing head and a connection structure; a steel inner barrel comprising an inner barrel body and epitaxial structures arranged at two ends of the inner barrel body, where the inner barrel body is connected to the outer barrel body via the epitaxial structures; and, an insulation layer constituted by a gap between the steel inner barrel and the concrete outer barrel, where the insulation layer has filled therein an insulation medium. The unitary group barrel is constituted by one or at least two unitary barrels. The offshore platform comprises the unitary barrel. The unitary barrel has a high structural strength, low construction and building difficulty, and reduced complexity.
Patent CA-2898284-A1 (CA)
Inventor: ATLASMAN TATYANA
IPC: A23L19/00
Filed: 2014-01-22
Abstract: The present invention provides a therapeutic composition comprising heat-treated clear tomato concentrate (CTC), which has been found to possess both anti-inflammatory and bone-health promoting effects. The present invention is also directed to a composition comprising heat-treated CTC in combination with one or more carotenoids.
Patent CA-2899080-A1 (CA)
Title: Apparatus and method for generating a frequency enhancement signal using an energy limitation operation
Inventor: DISCH SASCHA
IPC: G10L21/038
Filed: 2014-01-28
Abstract: An apparatus for generating a frequency enhancement signal (130), comprises: a signal generator (200) for generating an enhancement signal from a core signal (120), the enhancement signal comprising an enhancement frequency range not included in the core signal, wherein a time portion of the enhancement signal comprises subband signals for a plurality of subbands; a synthesis filterbank (300) for generating the frequency enhanced signal (140) using the enhancement signal (130), wherein the signal generator (200) is configured for performing an energy limitation in order to make sure that the frequency enhanced signal (140) obtained by the synthesis filterbank (300) is so that an energy of a higher band is, at the most, equal to an energy in a lower band or is greater than an energy of a higher band, at the most, by a predefined threshold.
Patent CA-2900054-A1 (CA)
Title: Methods for single-molecule analysis
Inventor: CAO HAN
IPC: C12Q1/68
Filed: 2014-02-03
Abstract: Methods for single-molecule preparation and analysis are disclosed herein. The methods can, for example, be used for isolating and analyzing DNA from various biological samples.
Patent CA-2901671-A1 (CA)
Title: .gamma.-diketones as wnt/.beta. -catenin signaling pathway activators
Inventor: KUMAR KC SUNIL
IPC: A61K31/33
Filed: 2014-02-21
Abstract: The present disclosure provides ?-diketones or analogs thereof, that activate Wnt/ß-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.
Patent CA-2903900-A1 (CA)
Inventor: UHLE CHRISTIAN
IPC: H04S3/00
Filed: 2013-10-23
Abstract: An apparatus for generating one or more audio output channel signals depending on two or more audio input channel signals is provided. Each of the two or more audio input channel signals comprises direct signal portions and ambient signal portions. The apparatus comprises a filter determination unit (110) for determining a filter by estimating first power spectral density information and by estimating second power spectral density information. Moreover, the apparatus comprises a signal processor (120) for generating the one or more audio output channel signals by applying the filter on the two or more audio input channel signals. The first power spectral density information indicates power spectral density information on the two or more audio input channel signals, and the second power spectral density information indicates power spectral density information on the ambient signal portions of the two or more audio input channel signals. Or, the first power spectral density information indicates the power spectral density information on the two or more audio input channel signals, and the second power spectral density information indicates power spectral density information on the direct signal portions of the two or more audio input channel signals. Or, the first power spectral density information indicates the power spectral density information on the direct signal portions of the two or more audio input channel signals, and the second power spectral density information indicates the power spectral density information on the ambient signal portions of the two or more audio input channel signals.
Patent CA-2908767-A1 (CA)
Title: Method for producing hematite for ironmaking
Inventor: OHARA GO
IPC: C22B3/04
Filed: 2014-04-14
Abstract: Proposed is a method for separating a leaching residue from which can be obtained a hematite-containing material that can be used as a starting material for iron manufacturing, and provided is a production method that, from the leaching residue, generates hematite for iron manufacturing. The method for producing hematite for iron manufacturing and using as the starting material a leaching residue obtained from a hydrometallurgy plant of nickel oxide ore using a high-pressure acid leaching method is characterized by sequentially performing at least the two steps that are a step for separating the leaching residue into an underflow and an overflow using a wet cyclone and a step for separating the separated overflow using magnetic force into that which is strongly magnetic and that which is weakly magnetic, the step for separating using magnetic force using a high magnetic field magnetic separation device.
Patent CA-2909873-A1 (CA)
Title: Nuclear magnetic resonance tool calibration
Inventor: JACHMANN REBECCA CORINA
IPC: G01N24/08
Filed: 2013-05-30
Abstract: Various embodiments include apparatus and methods to calibrate a nuclear magnetic resonance tool. Example calibration techniques may include using intended ninety degree pulses as a control mechanism to evaluate echo pulses from generating pulse sequences. Example calibration techniques may include comparing a sequence of measurement signals with a reference sequence. Additional apparatus, systems, and methods are disclosed.
Patent CA-2911172-A1 (CA)
Title: Controlled release pharmaceutical formulations
Inventor: LAING PETER
IPC: A61K9/00
Filed: 2014-04-29
Abstract: Disclosed herein are drug release polymer compounds and compositions comprising prostacyclin compounds of Formula (I), and methods of preparing the same. A preferred polymer has a repeating unit of the following structure:
Patent CA-2912358-A1 (CA)
Inventor: HARRIS PAUL RONALD
IPC: A61B5/0295
Filed: 2013-02-04
Abstract: A system that continuously monitors cardiovascular health using an electrocardiography (ECG) source synchronized to an optical (PPG) source, without requiring invasive techniques or ongoing, large-scale external scanning procedures. The system includes an ECG signal source with electrodes contacting the skin, which generates a first set of information, and a mobile device having a camera which acts as a PPG signal source that generates a second set of information. Together with the mobile device's processor, configured to receive and process the first and second sets of information, from which the time differential of the heart beat pulmonary pressure wave can be calculated, continuous data related to cardiovascular health markers such as arterial stiffness can be determined. Variations of the ECG source may include a chest strap, a plug-in adaptor for the mobile device, or electrodes built into the mobile device.
Patent CA-2916362-A1 (CA)
Inventor: SUZUKI MASAMI
IPC: A61P43/00
Filed: 2014-06-23
Abstract: The present inventors succeeded in producing: an anti-Epiregulin antibody exhibiting a cross-species reactivity between a non-human animal crab-eating monkey and a human animal; an anti-Epiregulin antibody with suppressed chemical decomposition; an anti-Epiregulin antibody having a lowered isoelectric point; an anti-Epiregulin antibody having an elevated thermal denaturation midpoint temperature; and an anti-Epiregulin antibody having a reduced amount of aggregates, by appropriately substituting an amino acid residue in the variable region sequence of a humanized EP27 antibody that is capable of exhibiting a cytotoxic activity and neutralization activity on a cancer cell, said cancer cell expressing human Epiregulin, to thereby inhibit the proliferation of the cancer cell. Also, the present inventors succeeded in creating a therapeutic agent for non-small-cell lung carcinoma excluding adenocarcinoma, said therapeutic agent comprising one of the aforesaid antibodies as an active ingredient.
Patent CA-2916997-A1 (CA)
Title: Axial fluid valves
Inventor: HOFF ELLIOT JAMES
IPC: F16K3/24
Filed: 2014-07-15
Abstract: Axial fluid valves having curved or angled valve bodies are described herein. An example apparatus disclosed herein includes a valve body (102, 104) defining a passageway (110) between an inlet (112) and an outlet (114), the inlet is aligned along a first axis (164) and the outlet is aligned along a second axis (166). The example apparatus includes a flow control member (106) interposed between the inlet and the outlet. The example apparatus also includes an actuator (108) having a stem (128) coupled to the flow control member to move the flow control member along a third axis in the passageway. In the example apparatus, the third axis (168) is substantially parallel to and offset from at least one of the first axis or the second axis.
Patent CA-2919395-A1 (CA)
Title: Method and electrochemical cell for managing electrochemical reactions
Inventor: SWIEGERS GERHARD FREDERICK
IPC: H01M4/00
Filed: 2014-07-30
Abstract: ABSTRACT A method and/or electrochemical cell for utilising one or more gas diffusion5 electrodes (GDEs) in an electrochemical cell, the one or more gas diffusion electrodes have a wetting pressure and/or a bubble point exceeding 0.2 bar. The one or more gas diffusion electrodes can be subjected to a pressure differential between a liquid side and a gas side. A pressure on the liquid side of the GDE over the gas side does not exceed the wetting pressure of the GDE during10 operation (in cases where a liquid electrolyte side has higher pressure), and/or a pressure on the gas side of the GDE over the liquid side, does not exceeds the bubble point of the GDE (in cases where the gas side has the higher pressure).
Patent CA-2920481-A1 (CA)
Title: Improved lithium metal oxide rich cathode materials and method to make them
Inventor: STOTTLEMYER ALAN L
IPC: H01M4/525
Filed: 2014-08-05
Abstract: A method of doping elements (particularly those that do not have stable divalent oxidation states) into lithium rich metal oxides useful in lithium ion batteries is comprised of the following steps. A dopant metal is dissolved in a liquid, which includes being present as a colloid, to form a solution. The solution is added to a particulate lithium rich metal oxide precursor while agitating said precursor to form a mixture. The solution is added in an amount that is at most that amount which would make the mixture a paste. The liquid is removed to form a doped lithium rich metal oxide precursor. A source of lithium is added. The doped lithium rich metal oxide precursor is heated to form the lithium rich metal oxide.
Patent CA-2921259-A1 (CA)
Inventor: KESSIE ANDREW SCOTT
IPC: G01M15/14
Filed: 2016-02-18
Abstract: A method of evaluating a part is characterized by obtaining data representing a distress rank model (DRM) and a cumulative damage model (CDM) for the part. Based on the data, the method ascertains a DRM value for the part and a CDM value for the part. The method determines whether the DRM value is at or above a predetermined DRM threshold and whether a CDM value is at or above a predetermined CDM threshold. If either the DRM value or the CDM value is at or above at least one respective threshold, an action related to the part is generated.
Patent CA-2922480-A1 (CA)
Title: Composition a base d'acide gras polyinsature et de vitamine d destinee a une administration par voie orale pour ameliorer la qualite de la chevelure
Inventor: BRU CAROLE
IPC: A61Q5/00
Filed: 2014-08-29
Abstract: La présente invention a pour objet l'utilisation cosmétique par voie orale d'une association d'actifs comprenant au moins un acide gras polyinsaturé et de la vitamine D, pour améliorer la qualité de la chevelure. Cette association d'actifs peut en outre comprendre, à titre d'actif additionnel, de la vitamine E, de la vitamine C, un caroténoïde, du gluconate de zinc ou leurs combinaisons. L'association d'actifs est, de préférence, mise en uvre dans une composition cosmétique destinée à une administration par voie orale, telle qu'un complément alimentaire.
Patent CA-2922571-A1 (CA)
Title: Activity tracking device
Inventor: YI CHIANG YING
IPC: G06F13/00
Filed: 2014-08-20
Abstract: An activity tracking device has a display screen, a data store, a main processor communicatively coupled with the data store, a device profile configuration stored in the data store, and a user profile configuration stored in the data store. The device profile configuration has a device identifier, processor identifiers, and device statuses. The user profile configuration has a user identifier, and a minimum user activity parameter. The minimum user activity parameter is determined based on one or more historical activity parameters resulting from actual user activity as tracked by the activity tracking device, stored in the data store, and configured in the user profile configuration.
Patent CA-2923212-A1 (CA)
Inventor: BELMONTE OLIVIER
IPC: B64C11/48
Filed: 2014-09-22
Abstract: La présente invention porte sur un vérin hydraulique comportant un support fixe (30), un cylindre (24) mobile en translation par rapport au support, un piston (22) fixe à l'intérieur du cylindre délimitant deux chambres avec le cylindre (24) et un dispositif d'alimentation des chambres en fluide hydraulique à l'amont depuis le support fixe (30, 31). Le vérin est caractérisé par le fait que le dispositif d'alimentation comprend des canalisations télescopiques (25, 26, 28), chaque canalisation télescopique comprenant deux éléments tubulaires coulissant l'un dans l'autre, un premier élément tubulaire étant solidaire du support fixe (31) à une extrémité et le deuxième élément tubulaire étant solidaire du cylindre en au moins deux points distants l'un de l'autre le long d'une génératrice du cylindre. L'invention est appliquée à la commande du pas des pales d'une hélice de turbomoteur.
Patent CA-2923854-A1 (CA)
Inventor: HENDERSON LEWIS T
IPC: H02B1/26
Filed: 2014-09-11
Abstract: La présente invention concerne un dispositif de commande pour une enceinte, le dispositif de commande comprenant une première partie positionnée à proximité d'une face arrière d'une surface d'enceinte de l'enceinte, et une deuxième partie positionnée à proximité d'une face avant de la surface d'enceinte. La première partie peut comprendre un piston ayant une extrémité proximale et une extrémité distale, l'extrémité proximale étant adjacente à la surface d'enceinte. La première partie peut comprendre en outre un premier aimant ayant une première polarité et disposé à l'extrémité proximale du piston. La première partie peut comprendre en outre au moins un contact en communication avec l'extrémité distale du piston, l'au moins un contact a un premier état et un deuxième état. La deuxième partie peut comprendre un deuxième aimant ayant une deuxième polarité, le deuxième aimant ayant une position associée et une position dissociée.